Bristol Myers Squibb (BMY) Dividends payables (2009 - 2015)

Bristol Myers Squibb (BMY) has 7 years of Dividends payables data on file, last reported at $655.0 million in Q4 2015.

• Dividends payables for Q4 2015 came in at $655.0 million, up 1.55% year-over-year; the trailing twelve-month figure through Dec 2015 was $655.0 million (up 1.55% YoY), and the FY2015 annual result was $655.0 million, up 1.55% from the prior year.
• Dividends payables grew to $655.0 million in Q4 2015 per BMY's latest filing, from $636.0 million in the prior quarter.
• Over five years, Dividends payables peaked at $655.0 million in Q4 2015 and troughed at $578.0 million in Q1 2011.
• A 5-year average of $612.2 million and a median of $608.5 million in 2012 frame the typical range for Dividends payables.
• On a YoY basis, Dividends payables climbed as much as 4.62% in 2013 and fell as far as 1.34% in 2013.
• A 5-year view of Dividends payables shows it stood at $597.0 million in 2011, then gained by 1.51% to $606.0 million in 2012, then increased by 4.62% to $634.0 million in 2013, then climbed by 1.74% to $645.0 million in 2014, then increased by 1.55% to $655.0 million in 2015.
• Business Quant data shows BMY's Dividends payables at $655.0 million in Q4 2015, $636.0 million in Q3 2015, and $634.0 million in Q2 2015.